PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Xeris Biopharma’s glucagon injection becomes available in UK

Tetris Pharma’s Ogluo is the first ready-to-use, pre-mixed and pre-measured glucagon injection. Tetris Pharma has launched Ogluo (glucagon injection) in the UK an...
Continue Reading →
News

NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma

The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund. NICE has issued guidance recommending Merck/MSD’s Keytrud...
Continue Reading →
News

Health minister welcomes new treatments for COVID-19 patients

The treatments are being offered as an addition to vaccinations to maximise protection against COVID-19. Xevudy (sotrovimab) has been approved for use by the Medi...
Continue Reading →
News

UK COVID-19 vaccine pledge faces logistical challenges

The public has been assured more sites, mobile units and pop-ups would be set up across the country to fulfil the vaccination pledge ahead of the original deadline o...
Continue Reading →
News

SMC approves first immunotherapy combination for advanced bowel cancer patients with rare mutation

Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland for patients who have previously failed fluoropyrimidine-based ch...
Continue Reading →
News

European Commission approves Pfizer’s atopic dermatitis treatment

The approval from the European Commission (EC) is based on the results of five clinical studies, involving over 2,800 patients. The European Commission has approv...
Continue Reading →
News

Five-drug combination for ultra-high-risk bone marrow cancer identified

A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial metho...
Continue Reading →
News

Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals

A widely used and inexpensive Type 2 diabetes drug, once hoped to hold enormous promise in treating breast cancer, does not prevent or stop the spread of the most co...
Continue Reading →
News

Roche completed the repurchase of Roche shares from Novartis

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it completed the repurchase of Roche shares that had been held by Novartis. On 4 November 2021, Roche and Nov...
Continue Reading →
News

Positive Phase III results for plant-based COVID-19 vaccine

Medicago and GlaxoSmithKline (GSK) have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy study of Medicago’s plan...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026